EMD Millipore talks single use technology at Interphex 2011

This content item was originally published on www.biopharma-reporter.com, a William Reed online publication.

By Gareth Macdonald

- Last updated on GMT

How have single-use technologies changed drug production? How do you dispose of a disposable technology? What will drive the market going forward? EMD Millipore answered these questions and more at Interphex 2011.

in-Pharmatechnologist.com spoke with EMD Millipore’s Vikas Gupta who said that single-use tech is having a dramatic impact on the pharma sector, particularly as it moves from the blockbuster model to a multi-drug, multi-site production paradigm.

He explained that in the last decade the application of single-use technology was primarily limited to buffer and media filtration and storage but in recent years it has begun to be used across all operations, from cell culture all the way to final fill/finish.

Gupta also discussed EMD Millipore’s unique approach to disposing of single-use technology, explaining that the firm converts used production technologies into fuel for brick and cement manufacturing.

Related news

Show more

Related products

Solution for challenging antibodies – Planova™ S20N

Solution for challenging antibodies – Planova™ S20N

Content provided by Asahi Kasei Medical Co., Ltd. | 24-Sep-2024 | White Paper

Designed as a next generation cellulose-based virus removal filter, Planova™ S20N has demonstrated robust filtration performance for challenging molecules...

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...